Navigation Links
Many Patients With Heart Attack Delay Hospital Care
Date:11/8/2010

By Amanda Gardner
HealthDay Reporter

MONDAY, Nov. 8 (HealthDay News) -- The time it takes for a patient to get to an emergency room when experiencing the symptoms of a heart attack have remained stubbornly high for the past decade, despite efforts to fix that, researchers report.

A new study in the Nov. 8 issue of Archives of Internal Medicine found that it took heart attack patients an average of 2.6 hours to get to the hospital after first noticing symptoms -- this despite education efforts to get people to call for help or leave for the hospital within five minutes of chest pain, jaw pain, shortness of breath or other symptoms.

Progress has been made in cutting system delays -- meaning what happens after a patient enters into medical care -- with "door-to-balloon" (such as angioplasty) times now well below 90 minutes, and sometimes as low as 50 or 60 minutes. Time is especially critical for patients with a type of heart attack called ST-segment elevation myocardial infarction (STEMI), which tends to be the more severe form of heart attack.

Previous research has shown that the time from onset of symptoms to arriving at the hospital for STEMI patients is about 114 minutes, or less than two hours, the study authors said.

The new study looked at non-STEMI patients.

"People have put in a lot of effort to reduce the time from the paramedic to getting to the hospital and into the cardiac cath [catheterization] lab where you open up the blocked vessels, and there's been great success with that," said Dr. Frederick Ling, director of the cardiac catheterization laboratory at the University of Rochester Medical Center in Rochester, N.Y. "The issue is that there really has to be a lot more focus now on the patient side, but the patient part of it is much harder to do."

Study lead author Dr. Henry H. Ting, an interventional cardiologist with the Mayo Clinic in Rochester, Minn., said: "A heart a
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. New Drug, Pradaxa, May Prevent Second Stroke in Certain Heart Patients
2. Real-time physician electronic alerts reduce unnecessary blood testing in elderly patients
3. Anti-Delirium Drug May Harm Critically Ill Patients
4. Insufficient vitamin D levels in CLL patients linked to cancer progression and death
5. Experts issue recommendations for treatment of post-bariatric surgery patients
6. Combining radiation therapy, chemotherapy safely treats head and neck cancer patients
7. Patients Who Swallow Foreign Objects a Costly Burden to Health Care
8. Prognostic markers for prostate cancer patients who receive radiation after surgery
9. Study Casts Doubt on Hospice Admission Criteria for Patients With Dementia
10. Program May Help Prevent Falls in Hospitalized Patients
11. Long Hours Put Surgeons, Patients at Risk, Study Suggests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... have identified new pain relief targets that could ... BBSRC-funded researchers at King,s College London made the ... in the periphery of the body. , Dr ... identifying mechanisms underlying pain generation and our findings ... side effects." , One potential side effect of ...
(Date:4/17/2014)... California, San Diego School of Medicine report that older ... recent major loss are more likely to be compassionate ... is published in this month,s issue of the ... behaviors are associated with better health and well-being as ... to improve the outcomes of individuals whose deficits in ...
(Date:4/17/2014)... Northwestern University synthetic biology team has created a ... programmable therapeutics that could travel the body and ... , Engineering cell-based, biological devices that monitor and ... clinical synthetic biology. However, no existing technology enabled ... patient,s physiological state and respond in a customized ...
(Date:4/17/2014)... cause of neuronal death in Parkinson,s disease is still ... be mistaken for foreign invaders and killed by the ... diseases like type I diabetes, celiac disease, and multiple ... April 16, 2014, in Nature Communications . , ... Parkinson,s disease; but if true, it could lead to ...
(Date:4/17/2014)... Alliance, a nonprofit organization that focuses on conservation and ... examining the current state of knowledge of the deadly ... global surveillance strategies to combat the emergence of infectious ... West Africa that has claimed the lives of 122 ... According to the World Health Organization (WHO), the deadly ...
Breaking Medicine News(10 mins):Health News:New pain relief targets discovered 2Health News:The ilk of human kindness 2Health News:Building 'smart' cell-based therapies 2Health News:Is Parkinson's an autoimmune disease? 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 3
... , ATLANTA, Sept. 8 Craneware, Inc. (AIM: CRW.L), a leader in ... for the year ended June 30, 2009. , , Financial ... of contracted sales in the year totaling $43.2m (FY08: $25.7m), 68% up from the ... increase in revenues to $23.0m (FY08: $18.7m) , ...
... , Senators Bob Dole and Tom Daschle join ... bipartisan agreement in health reform , , ... Health Care Together will host a bipartisan health care forum to ... the health reform debate. The event entitled, "Common Sense Collaboration: ...
... , , , BRISTOL, Va. ... and HealthSouth Corporation (NYSE: HLS ) today announced that ... awarded a certificate of public need (COPN) to open a new ... more patients in Bristol and throughout Southwest Virginia to have access ...
... , , , ... Sept. 8 Reportlinker.com announces that a new market research report ... Gastrointestinal Endoscopy Devices , , ... the US market for Gastrointestinal Endoscopy Devices in Millions of US$ ...
... , , Texas ... Jobs, Improve Patient Access to Care , , ... period filled with wide-ranging local discussion of health care reform, the Texas ... care reform in Washington can help drive momentum and discussion in Texas ...
... , SOMERSET, N.J., Sept. 8 ... of EDLUAR(TM) (zolpidem tartrate sublingual tablets) in the United ... insomnia characterized by difficulties with falling asleep. EDLUAR is ... is the most prescribed treatment for insomnia. Zolpidem tartrate ...
Cached Medicine News:Health News:Craneware Announces Fiscal Year-End Results 2Health News:Craneware Announces Fiscal Year-End Results 3Health News:Bipartisan Policy Center and Better Health Care Together to Host Joint Health Care Forum Tomorrow 2Health News:Wellmont, HealthSouth Form Joint Venture to Open a New Rehabilitation Hospital in Southwest Virginia 2Health News:Wellmont, HealthSouth Form Joint Venture to Open a New Rehabilitation Hospital in Southwest Virginia 3Health News:Wellmont, HealthSouth Form Joint Venture to Open a New Rehabilitation Hospital in Southwest Virginia 4Health News:Wellmont, HealthSouth Form Joint Venture to Open a New Rehabilitation Hospital in Southwest Virginia 5Health News:Reportlinker Adds Gastrointestinal Endoscopy Devices Report 2Health News:Reportlinker Adds Gastrointestinal Endoscopy Devices Report 3Health News:Reportlinker Adds Gastrointestinal Endoscopy Devices Report 4Health News:Reportlinker Adds Gastrointestinal Endoscopy Devices Report 5Health News:Reportlinker Adds Gastrointestinal Endoscopy Devices Report 6Health News:Reportlinker Adds Gastrointestinal Endoscopy Devices Report 7Health News:Reportlinker Adds Gastrointestinal Endoscopy Devices Report 8Health News:Texas Kidney Community Expresses Hope DC Health Care Reform Debate Can Help Drive Continued Progress in Texas Opening Needed Dialysis Facilities 2Health News:Texas Kidney Community Expresses Hope DC Health Care Reform Debate Can Help Drive Continued Progress in Texas Opening Needed Dialysis Facilities 3Health News:Meda Introduces EDLUAR(TM), the First and Only Sublingual Tablet That Contains the Most Prescribed Sleep Medication, Zolpidem Tartrate 2Health News:Meda Introduces EDLUAR(TM), the First and Only Sublingual Tablet That Contains the Most Prescribed Sleep Medication, Zolpidem Tartrate 3Health News:Meda Introduces EDLUAR(TM), the First and Only Sublingual Tablet That Contains the Most Prescribed Sleep Medication, Zolpidem Tartrate 4
(Date:1/15/2014)... Tegra Medical is very pleased to announce the appointment ... Chief Executive Officer.  Mark was promoted from his current role ... company,s four facilities in Massachusetts , ... Tegra Medical in 2012 with 20+ years of broad-based operations, ...
(Date:1/15/2014)... Jan. 15, 2014 Reportlinker.com announces that ... in its catalogue: ... Analysis http://www.reportlinker.com/p01957812/Insulin-Pump-Market--Forecast-–-Worldwide-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ... Insulin Pumps are gaining ...
(Date:1/15/2014)... Mass. , Jan. 15, 2014  Zafgen, Inc., ... unmet needs of severely obese patients, today announced ... beloranib, a selective inhibitor of methionine aminopeptidase 2 ... severe form of genetic obesity.  These results showed ...
Breaking Medicine Technology:Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4
... Pa., Oct. 29 Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL) today ... Credit Suisse Healthcare Conference to be held November 10-12, 2010 ... Fickenscher, Chief Financial Officer, is scheduled to present an overview ... ET on Thursday, November 11, 2010. To listen ...
... Calif., Oct. 28 VIVUS, Inc. (Nasdaq: ... Response Letter (CRL) from the U.S. Food and Drug ... the investigational new drug QNEXA® (phentermine/topiramate) Controlled-Release Capsules. The ... the NDA cannot be approved in its present form. ...
Cached Medicine Technology:Auxilium Pharmaceuticals to Present at the 2010 Annual Credit Suisse Healthcare Conference 2Auxilium Pharmaceuticals to Present at the 2010 Annual Credit Suisse Healthcare Conference 3FDA Issues Complete Response Letter to VIVUS Regarding New Drug Application for QNEXA® 2FDA Issues Complete Response Letter to VIVUS Regarding New Drug Application for QNEXA® 3FDA Issues Complete Response Letter to VIVUS Regarding New Drug Application for QNEXA® 4FDA Issues Complete Response Letter to VIVUS Regarding New Drug Application for QNEXA® 5
Portable shields for your safety and convenience....
The Bronze Metalite Constructed of optical-grade steel with bronze electroplate. Fitted lead side shields that create a seal to the front of the lenses for increased scatter protection....
Full-Height Radiation Barriers provide full-body shielding and reduce eye strain during extended procedures....
Height-Adjustable Mobile X-ray Barrier lets you get close to your patient during special procedures like cardiac cath. 24"H x 36"W viewing panel shields the upper body of one or two people and swivel...
Medicine Products: